Notice of Share Buyback of Restricted Stock Award Shares

Overview of the Disposal

Takeda Pharmaceutical Company Limited has resolved at the Board of Directors meeting to dispose of 524,400 treasury shares at 186 yen on August 14, 2026. This disposal is part of the restricted stock award system, generating proceeds of 97,538,400 yen. The disposed shares will be allocated to directors and employees, with restrictions on transfer or pledge rights. The purpose of the disposal is to enhance motivation to contribute to stock price appreciation and corporate value improvement as part of its compensation scheme.

Impact on Shareholders and Future Outlook

Since this share buyback does not involve issuance of new shares, the direct dilution effect on shareholders is considered limited. The funds raised will likely be used for future business investments and growth strategies. The disposal is scheduled for August 14, 2026, and shareholders and investors should pay attention to the company’s future stock price trends and growth strategies.